Phospholipids and lipid-based formulations in oral drug delivery. 2010

Gert Fricker, and Torsten Kromp, and Armin Wendel, and Alfred Blume, and Jürgen Zirkel, and Herbert Rebmann, and Constanze Setzer, and Ralf-Olaf Quinkert, and Frank Martin, and Christel Müller-Goymann
Phospholipid Research Center, Im Neuenheimer Feld 582, 69120, Heidelberg, Germany. gert.fricker@uni-hd.de

Phospholipids become increasingly important as formulation excipients and as active ingredients per se. The present article summarizes particular features of commonly used phospholipids and their application spectrum within oral drug formulation and elucidates current strategies to improve bioavailability and disposition of orally administered drugs. Advantages of phospholipids formulations not only comprise enhanced bioavailability of drugs with low aqueous solubility or low membrane penetration potential, but also improvement or alteration of uptake and release of drugs, protection of sensitive active agents from degradation in the gastrointestinal tract, reduction of gastrointestinal side effects of non-steroidal anti-inflammatory drugs and even masking of bitter taste of orally applied drugs. Technological strategies to achieve these effects are highly diverse and offer various possibilities of liquid, semi-liquid and solid lipid-based formulations for drug delivery optimization.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

Gert Fricker, and Torsten Kromp, and Armin Wendel, and Alfred Blume, and Jürgen Zirkel, and Herbert Rebmann, and Constanze Setzer, and Ralf-Olaf Quinkert, and Frank Martin, and Christel Müller-Goymann
January 2015, Current drug metabolism,
Gert Fricker, and Torsten Kromp, and Armin Wendel, and Alfred Blume, and Jürgen Zirkel, and Herbert Rebmann, and Constanze Setzer, and Ralf-Olaf Quinkert, and Frank Martin, and Christel Müller-Goymann
February 2019, Biomolecules,
Gert Fricker, and Torsten Kromp, and Armin Wendel, and Alfred Blume, and Jürgen Zirkel, and Herbert Rebmann, and Constanze Setzer, and Ralf-Olaf Quinkert, and Frank Martin, and Christel Müller-Goymann
January 2012, Drug discovery today. Technologies,
Gert Fricker, and Torsten Kromp, and Armin Wendel, and Alfred Blume, and Jürgen Zirkel, and Herbert Rebmann, and Constanze Setzer, and Ralf-Olaf Quinkert, and Frank Martin, and Christel Müller-Goymann
July 2007, Advanced drug delivery reviews,
Gert Fricker, and Torsten Kromp, and Armin Wendel, and Alfred Blume, and Jürgen Zirkel, and Herbert Rebmann, and Constanze Setzer, and Ralf-Olaf Quinkert, and Frank Martin, and Christel Müller-Goymann
May 2017, Pharmaceutical development and technology,
Gert Fricker, and Torsten Kromp, and Armin Wendel, and Alfred Blume, and Jürgen Zirkel, and Herbert Rebmann, and Constanze Setzer, and Ralf-Olaf Quinkert, and Frank Martin, and Christel Müller-Goymann
December 2001, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia,
Gert Fricker, and Torsten Kromp, and Armin Wendel, and Alfred Blume, and Jürgen Zirkel, and Herbert Rebmann, and Constanze Setzer, and Ralf-Olaf Quinkert, and Frank Martin, and Christel Müller-Goymann
February 2013, Journal of pharmaceutical sciences,
Gert Fricker, and Torsten Kromp, and Armin Wendel, and Alfred Blume, and Jürgen Zirkel, and Herbert Rebmann, and Constanze Setzer, and Ralf-Olaf Quinkert, and Frank Martin, and Christel Müller-Goymann
January 2015, Current molecular biology reports,
Gert Fricker, and Torsten Kromp, and Armin Wendel, and Alfred Blume, and Jürgen Zirkel, and Herbert Rebmann, and Constanze Setzer, and Ralf-Olaf Quinkert, and Frank Martin, and Christel Müller-Goymann
January 2020, ADMET & DMPK,
Gert Fricker, and Torsten Kromp, and Armin Wendel, and Alfred Blume, and Jürgen Zirkel, and Herbert Rebmann, and Constanze Setzer, and Ralf-Olaf Quinkert, and Frank Martin, and Christel Müller-Goymann
June 2021, Pharmaceutical research,
Copied contents to your clipboard!